KAUST and Oxford Nanopore Technologies have signed an MoU to collaborate on multi-omics research, building on previous work such as the NanoRanger technique developed by KAUST's Mo Li. KAUST will gain early access to Oxford Nanopore’s sequencing technology, while Oxford Nanopore will access KAUST's Core Labs. Why it matters: This partnership enhances KAUST's research capabilities in areas like rare diseases and desert agriculture, and provides Oxford Nanopore with a launchpad to engage with Saudi Arabia's research community.
KAUST and KFSHRC have developed NanoRanger, a new gene sequencing system for identifying mutations causing genetic diseases. NanoRanger offers a faster and simpler process to detect DNA abnormalities at base resolution, building on existing long-read sequencing technologies. The system is designed to be cheaper and faster, targeting diseases prevalent in Saudi Arabia due to consanguinity. Why it matters: The technology has the potential to improve diagnosis and treatment of Mendelian diseases, which are especially prevalent in the Arab world.
A KAUST-led research team is deploying DNA sequencing technology originally used on the International Space Station to analyze DNA samples in extreme environments along the Saudi Red Sea coast. The portable technology enables on-site extraction, concentration, and sequencing of samples from coral reefs and mangrove forests, minimizing DNA deterioration. Preliminary results indicate a more diverse and complex microbiome than previously found. Why it matters: This application of space-based technology to marine conservation in the Red Sea could provide critical insights into how coral reefs and mangroves adapt to climate change, informing preservation and restoration efforts.
A KAUST-led team developed NIRVANA, a portable, briefcase-sized device for rapid detection and sequencing of SARS-CoV-2, influenza, and other viruses. The test utilizes isothermal recombinase amplification (RPA) and was validated on clinical samples and wastewater. NIRVANA can differentiate SARS-CoV-2 strains and doesn't require expensive infrastructure. Why it matters: This innovation enables rapid, decentralized virus detection and surveillance, crucial for pandemic response and monitoring new variants across the region.
The KAUST Pathogen Genomics Laboratory (PGL), led by Professor Arnab Pain, is using DNA and RNA sequencing to study the SARS-CoV-2 virus. The lab is part of KAUST's Rapid Research Response Team (R3T), supporting Saudi healthcare stakeholders in combating COVID-19. Pain and his Ph.D. student Sharif Hala are partnering with the Saudi-CDC and Ministry of Health hospitals to sequence Saudi SARS-CoV-2 samples. Why it matters: This effort provides crucial data for understanding and monitoring the virus's spread and evolution within the Kingdom, informing public health strategies.
A KAUST-led research team sequenced the first high-quality quinoa genome. This achievement may enhance our ability to feed the world's growing population. The research was conducted at King Abdullah University of Science and Technology. Why it matters: This breakthrough in genomics could lead to more resilient and nutritious crops, contributing to global food security efforts.
KAUST researchers have developed a CRISPR-Cas system using a heat-stable Cas13 protein (TccCas13a) from Thermoclostridium caenicola, compatible with RT-LAMP for rapid viral detection. The new assay, named OPTIMA-dx, enhances the specificity of RT-LAMP tests by reducing false positives in SARS-CoV-2 detection. The team, led by Dr. Magdy Mahfouz and doctoral student Ahmed Mahas, is transitioning the product to a startup phase for commercialization. Why it matters: This innovation could significantly improve point-of-care diagnostics for COVID-19 and other infections by providing a more accurate and easier-to-use testing method.
KAUST researchers are developing a streamlined COVID-19 diagnostic testing method using superparamagnetic nanoparticles (MNPs). The team, led by Assistant Professor Mo Li, aims to address reagent shortages and improve automation by creating an in-house extraction kit compatible with inactivated samples. Associate Professor Samir Hamdan identified a protocol for making silica-coated MNPs that survive inactivation reagents, enabling magnetic separation without centrifugation. Why it matters: This innovation could significantly increase testing capacity in Saudi Arabia and globally by reducing biosafety risks, reagent dependence, and manual processing.